ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 97

Systematic Review of Explanatory and Predictive Models in Rheumatology: Lack of Adhearance to Methodologic Standards

Daniel A. Albert, Medicine/Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Biomarkers and epidemiologic methods

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Prognostic and explanatory models are frequently utilized in clinical medicine to assist in judgments about diagnosis, prognosis, and treatment options. I surveyed predictive and explanatory models in rheumatology by conducting a systematic review using a PubMed (Medicine) search of a two year period, starting January 1, 2010, and ending December 31, 2011. This identified 564 articles using the key words: “Rheumatology,” and “prediction,” “models,” “stepwise,” “regression,” “multivariate,” “survival,” “prognosis,” “propensity scores,” “cost-effectiveness,” “decision analysis,” and “diagnosis.” 

Methods:

Out of the 564, I identified 76 articles, which I reviewed by abstract, and of these 42 articles were selected for review of their full text for adherence to methodologic standards.

Results:

Studies addressed a variety of issues including diagnosis, prognosis, identification of risk factors, biomarker studies, and disease activity. Data sets included institutional, multi-institutional, and national registries. Prospectively acquired, retrospectively acquired, and cross-sectional data was used. Regression techniques included logistic, linear, generalized estimating equation (GEE) and generalized linear model (GLM). Two studies used classification and regression trees (CART) analysis, 2 used a Bayesian approach, and one used neural network. Only one study explicitly described a power calculation. Internal validation by bootstrapping, split sample, or similar techniques was used in 13 of 42 studies, but only 4 used an external validation step. Discrimination (ROC Curves) or clinical utility (sensitivity and specificity) was described in 12 studies, but only 3 were subjected to calibration.

Conclusion:

A minority of published prognostic and explanatory models adhered to established methodologic standards. Very few studies contained a validation study and those that did were small and thus subject to over fitting. Several studies provided information on discrimination; however, few of these were calibrated using data from the validation study. A consensus scoring system of prognostic and explanatory models similar to that which has been utilized for systemic reviews needs to be constructed and adopted by the rheumatologic clinical epidemiology and clinical trial community.


Disclosure:

D. A. Albert,
None;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systematic-review-of-explanatory-and-predictive-models-in-rheumatology-lack-of-adhearance-to-methodologic-standards/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology